The SAKK Network Trial Award – a boost for clinical cancer research

Clinical cancer research trials make a major contribution to the ongoing refinement and improvement of existing cancer treatments. In its capacity as a decentralized academic research institute, the SAKK is announcing a competition to fund a new SAKK clinical trial in medical oncology and hematology. The competition, which has prize money of CHF 1 million, invites proposals from doctors in the SAKK network.


Trial proposals will be considered if:

  • its focus is innovative, pragmatic and interventional in nature
  • SAKK acts as sponsor according to ICH-GCP and the trial runs in Switzerland only
  • the SAKK patient advisory board was involved and
  • the Core Team of the respective research group has assessed and supports the idea


The competition invites proposals from physicians / researchers in the SAKK network whose primary place of research is Switzerland. Submissions from young doctors (aged 40 or under) are particularly welcome. For additional information on conditions of participation see “Conditions of Participation and Evaluation Procedure” document.


Deadline for Proposals: April, 18, 2024

Award Ceremony: SAKK Semi-Annual Meeting, June, 26, 2024

Further Information: If participants have questions, they should send an e-mail bearing the subject line “SAKK Network Trial Award” to